BetterLife Pharma appoints Charles Duncan as director, audit committee chair

Verifying
  • BetterLife Pharma appointed Charles Duncan as Director and Chair of its Audit Committee.
  • Duncan brings nearly 30 years of biotech investment experience to the company.
  • Duncan is a biotechnology strategist and former top Wall Street analyst.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.